Hemodynamic effects of short-term infusion of a vasopressin V1A/V2 receptor antagonist conivaptan in patients withchronic heart failure during submaximal exercise

Am Heart J. 2018 Sep:203:101-104. doi: 10.1016/j.ahj.2018.05.015. Epub 2018 Jun 14.

Authors

Louise Balling¹, Jakob Hartvig Thomsen², Emil Wolsk², Christian Hassager², Søren Boesgaard², Steven R Goldsmith³, Finn Gustafsson²

Affiliations

¹ Department of Cardiology, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark. Electronic address: louise.balling@gmail.com.
² Department of Cardiology, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark.
³ Hennepin County Medical Center, University of Minnesota, Minneapolis, MN.

PMID: 30057012
DOI: 10.1016/j.ahj.2018.05.015

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Antidiuretic Hormone Receptor Antagonists / administration & dosage
Benzazepines / administration & dosage*
Dose-Response Relationship, Drug
Double-Blind Method
Exercise Test / methods*
Exercise Tolerance / physiology*
Female
Follow-Up Studies
Heart Failure / diagnosis
Heart Failure / drug therapy*
Heart Failure / physiopathology
Hemodynamics / physiology*
Humans
Infusions, Intravenous
Male
Middle Aged
Randomized Controlled Trials as Topic*
Stroke Volume / physiology
Time Factors
Ventricular Function, Left / physiology

Substances

Antidiuretic Hormone Receptor Antagonists
Benzazepines
conivaptan

Associated data

ClinicalTrials.gov/NCT01752543